Listen to Gynecologic Oncology
By Gynecologic Oncology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Gynecologic Oncology
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 5
Reviews: 0
Episodes: 72
Description
Stay informed with the latest research and emerging topics in gynecologic oncology through our monthly podcast series. Each episode features a dynamic conversation hosted by one of our Journal’s esteemed editors, who speaks with the authors of the Editor’s Choice article and the accompanying commentarial.
| Episode | Date |
|---|---|
|
FIGO 2023 Upstaging: Overtreatment or Overdue Precision?
|
Sep 01, 2026 |
|
ERAS 2026: Key Updates Every Gynecologic Oncologist Should Know
|
Jul 31, 2026 |
|
Beyond the Binary: Unpacking Molecular Diversity in PMMR Endometrial Cancer
|
Jul 29, 2026 |
|
Cologuard-like test for identification of endometrial cancer through vaginal sampling
|
May 13, 2026 |
|
PARP Inhibitors in Ovarian Cancer: A Society of Gynecologic Oncology Podcast
|
May 08, 2026 |
|
Home the Same Day? Testing the Limits in Ovarian Cancer Debulking Surgery
|
Apr 09, 2026 |
|
Recognizing and Managing ADC-Associated Pulmonary Toxicities
|
Mar 16, 2026 |
|
In good SHAPE
|
Feb 01, 2026 |
|
ctDNA-Guided PARPi Therapy in Ovarian Cancer
|
Jan 01, 2026 |
|
Beyond treatment: The who, why, when, where and what of cancer follow up
|
Dec 01, 2025 |
|
Ovarian Cancer After Breast Cancer in Women with BRCA Variants
|
Nov 20, 2025 |
|
Making a difference: Molecules, mechanisms and more
|
Nov 17, 2025 |
|
Navigating Surgical Complexity After Ovarian Cancer Neoadjuvant Chemotherapy
|
Nov 06, 2025 |
|
Cervical Cancer Care in Focus: Consensus on Quality, Equity, and Radiation Therapy
|
Sep 26, 2025 |
|
Beyond Anesthesia: Self-Hypnosis in ERAS Programs
|
Aug 29, 2025 |
|
Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting
|
Jul 14, 2025 |
|
To divert or not to divert: that is the question
|
Jul 08, 2025 |
|
A randomized clinical trial of metformin in endometrial cancer
|
May 02, 2025 |
|
Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer
|
Mar 26, 2025 |
|
Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study
|
Mar 03, 2025 |
|
Clinical trials: Panacea or pitfall
|
Jan 27, 2025 |
|
FOLR1 status: Landscape beyond high grade serous ovarian cancer
|
Dec 30, 2024 |
|
Benefits of hormonal therapy for low grade serous ovarian cancer
|
Nov 25, 2024 |
|
Implementation and impact of a financial navigation program in gynecologic oncology
|
Oct 23, 2024 |
|
LVSI in Stage 1 Endometrial Cancer
|
Sep 26, 2024 |
|
Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer
|
Sep 02, 2024 |
|
2023 FIGO staging for endometrial cancer: a reappraisal on the path to continuous improvement
|
Jul 10, 2024 |
|
Shifting trends and sicker patients - the future of gynecologic cancer
|
May 13, 2024 |
|
SENTIREC-endo study: Is the juice worth the squeeze?
|
Apr 14, 2024 |
|
Caring for the Caregiver
|
Mar 12, 2024 |
|
Lunchbox Trial
|
Feb 14, 2024 |
|
Optimization of endometrial cancer survivorship through modification of lifestyle factors
|
Jan 30, 2024 |
|
Engagement with ERAS patients leads to improved outcomes
|
Jan 14, 2024 |
|
OS updates for Imagyn50
|
Nov 01, 2023 |
|
Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?
|
Oct 02, 2023 |
|
What is your center doing to improve genetic testing following abnormal MMR results in endometrial cancer?
|
Sep 01, 2023 |
|
The evolution of patient-centered endometrial cancer detection: testing tompon-based collection for methylated DNA markers
|
Aug 01, 2023 |
|
TKI Toxicities: A Society of Gynecologic Oncology Podcast
|
Jul 11, 2023 |
|
ERAS Society Updates: What Every Gyn Oncologist Should Know
|
Jul 03, 2023 |
|
Prioritizing and achieving diversity in clinical trial enrollment
|
Jun 01, 2023 |
|
The times they are a changin’ – the future of the specialty
|
May 01, 2023 |
|
Intrathoracic Surgery and Ovarian Cancer Cytoreduction: Why the Chest Matters
|
Apr 03, 2023 |
|
A Geo-Analyzer Tool that assessed insured patients in your metropolitan area with recurrent and metastatic cervix cancer
|
Mar 01, 2023 |
|
Molecular Testing for Endometrial Cancer: A Society of Gynecologic Oncology Podcast
|
Feb 16, 2023 |
|
Sentinel lymph node mapping in endometrial complex atypical hyperplasia: good idea or have we gone too far?
|
Feb 01, 2023 |
|
Burnout and gynecologic oncology - does the problem still exist?
|
Jan 02, 2023 |
|
Exceptional PARP inhibitor responders: the good and the bad
|
Dec 21, 2022 |
|
Management of primary low-grade serous ovarian carcinoma: are you up-to-date on the most contemporary prognostic factors and treatment strategies?
|
Dec 01, 2022 |
|
How do you manage the contralateral groin in early stage vulvar cancer with a unilateral positive sentinel lymph node?
|
Oct 14, 2022 |
|
Frailty assessment in gynecologic oncology - have you incorporated this into your practice?
|
Sep 14, 2022 |
|
Complications after cytoreductive surgery and its impact on survival: where do we go from here?
|
Jul 14, 2022 |
|
Immunotherapy Toxicities: A Society of Gynecologic Oncology Podcast
|
Jul 12, 2022 |
|
Long-term cardiovascular complications among gynecologic cancer survivors
|
Jun 15, 2022 |
|
Financial toxicity – the other side effect of cancer care
|
Jun 02, 2022 |
|
Reducing non-surgical readmissions in gynecologic oncology
|
Apr 14, 2022 |
|
Improving QOL for patients with cervical cancer: SLN biopsy
|
Mar 03, 2022 |
|
The ProMisE of molecular classification to standardize care in endometrial cancer
|
Mar 02, 2022 |
|
HRD: What does it really mean and are we looking at this the right way?
|
Feb 03, 2022 |
|
Optimizing Rural Ovarian Cancer Care
|
Jan 06, 2022 |
|
Recurrent Endometrial Cancer: A Society of Gynecologic Oncology Podcast
|
Dec 09, 2021 |
|
Looking Back at 2021: November Editor’s Choice
|
Nov 04, 2021 |
|
Differences in cervical cancer screening and follow-up for black and white women in the United States
|
Apr 08, 2021 |
|
March 2021: The Future Of Gynecologic Oncology: We are at a Crossroads
|
Mar 04, 2021 |
|
April 2020: Rare Tumors and Conditions
|
Oct 08, 2020 |
|
2020 Virtual Annual SGO Meeting Report
|
Aug 12, 2020 |
|
PARP Inhibitor Maintenance Therapy after Initial Chemotherapy for Advanced Ovary, Fallopian Tube and Primary Peritoneal Cancers
|
May 23, 2020 |
|
Present and Future Impact of COVID-19 on the Practice and Delivery on Gynecologic Oncology Care
|
Mar 26, 2020 |
|
Financial hardship among gynecologic cancer patients
|
Feb 26, 2020 |
|
Does the transcriptome of ovarian neoplasms provide insight into its potential behavior?
|
Jan 30, 2020 |
|
December 2019 Editor's Choice
|
Dec 24, 2019 |
|
Survival of endometrial cancer patients following lymphadenectomy or sentinel node procedure
|
Nov 30, 2019 |
|
Inaugural Gynecologic Oncology Podcast - When to stop hCG surveillance following chemotherapy for gastational trophoblastic neoplasia
|
Nov 04, 2019 |